Deferiprone tablets bulk supplier for pharma manufacturers

Deferiprone Tablets 250 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 250 mg, 500 mg

Reference Brands: Ferriprox(US)

Deferiprone chelates excess iron by binding to free iron in the bloodstream, forming complexes that are excreted in urine. It effectively reduces iron overload in conditions like thalassemia, preventing organ damage. Benefits include oral administration, rapid iron removal, and improved management of iron-related toxicity, enhancing patient health outcomes.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Deferiprone tablets, marketed as Ferriprox, are approved in the EU and US for treating iron overload, particularly in thalassemia patients. Regulatory approval requires a comprehensive dossier including clinical trial data, safety, efficacy, manufacturing standards, and pharmacovigilance plans. In the US, approval is granted by the FDA after rigorous review, while in the EU, EMA guidelines ensure compliance with regional standards. For expert guidance on dossier preparation, regulatory pathways, and successful market entry, visit PharmaTradz. Ensuring regulatory compliance is essential for the safe, effective, and timely approval of deferiprone tablets, supporting better patient management worldwide.

Deferiprone Tablets — third party manufacturing & bulk supply

Deferiprone Tablets 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Deferiprone Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Deferiprone Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Deferiprone Tablets →

Back to Listing

Frequently Asked Questions

Deferiprone tablets is listed as Tablet in 250 mg, 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Deferiprone tablets is referenced against Ferriprox(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.